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CLINICAL INVESTIGATION
Cuprammonium membranes stimulate interleukin 1 release and
arachidonic acid metabolism in monocytes in the absence
of complement
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Contact of blood with foreign surfaces, specifically dialysis mem-
branes, causes cell activation which has widely been assumed to be
mediated by complement (C). To explore the possibility of C-indepe-
ndent activation, we examined different cell types: PMN, human
monocytes and the cell lines U937 or HL6O, washed human platelets
and rat glomerular epithelial cell (primary) cultures (GEC), under
serum-free conditions and after addition of anti-C3 F(ab)2, respectively.
The monitored biological effects were release of PGE2, TXB2 or
interleukin I and generation of O2 radicals. To further explore the
mechanisms involved, phospholipid metabolism was studied by mea-
suring 1P3 and DG ('4C-arachidonic or oleic acid prelabeled U937 and
HL6O cells); changes of cytosolic Ca (Quin2 technique) were also
determined. The results show that in absence of C, brief (2 mm) contact
with cuprammonium (CU) stimulated: (a) PGE2 release in U937 and
human monocytes or GEC; (b) TXB2 release in washed platelets; (c)
slow interleukin I release by monocytes; and (d) generation of 02
radicals in PMN. Artifacts due to endotoxin were excluded by appro-
priate polymyxin control experiments and by comparison of effects with
those of bacterial LPS. Potential synthesis of C3 by U937 was excluded
by addition of anti-C3 F(ab)2. C-independent cell activation was accom-
panied by increase of DG, but not 1P3 (suggesting involvement of
protein C kinase dependent mechanisms) and by increased cytosolicCa . To further explore the initial signal involved, incubations were
carried out with covalently modified CU members (DEAE cellulose)
and in the presence of m concentrations of monosaccharides. Cationic
modification of CU membranes reduced C-independent cell activation.
Activation of arachidonic acid metabolism and increase in cytosolic
calcium by unmodified CU membranes were stereospecifically inhibited
by L-fucose, pointing to involvement of carbohydrates in the recogni-
tion signal.
Lack of perfect compatibility between blood and dialysis
equipment, specifically dialysis membranes, has plagued hemo-
dialysis since the first pioneer efforts of Haas [1]. Several side
effects of dialysis are the result of persisting membrane bioin-
compatibility, such as clotting or complement (C) activation [2].
More recently, it has also been hypothesized that interleukin I
synthesis is triggered in circulating monocytes within the di-
alyzer compartment [3]. The presence of some acute phase
reactions in dialysis patients has been related to interleukin 1
overproduction. Since the seminal studies of Craddock et al [4]
analysis of C-activation has played a prominent role in investi-
gations on membrane bioincompatibility. This may in part be
due to the relative ease with which fluid phase components of
the C system can be measured [5, 6]. Furthermore, there is no
doubt that blood cells of dialyzed patients are activated by C,
specifically CSa, as demonstrated recently by increased expres-
sion of the granulocyte-adhesion-promoting surface glycopro-
tein Mo 1 [7]. The ready demonstrability of C-activation does
not preclude, however, other mechanisms of cell activation.
Some indirect evidence points to the possibility of C-indepe-
ndent blood cell activation. Release of polymorphonuclear
leucocyte (PMN) markers, such as lactoferrin and alpha-l-
elastase was noted during dialysis with polymethylmetacrylate
or polysulfone membranes, despite only minor evidence of
activation of C in the fluid phase [8]. Furthermore, release of
platelet activating factor (PAF) and leucotrienes from washed
human PMN were seen after exposure to cuprophane in vitro
and in the absence of C [9]. The possibility of C-independent
cell activation is of more than academic interest, since bioen-
gineering efforts to develop more compatible dialysis mem-
branes must take into account alternate activation mechanisms.
To further explore the possibility of C-independent cell
activation by contact with cuprammonium membranes we
examined U 937 cells, human monocytes and washed human
platelets. To definitely exclude presence of traces of C, we also
studied primary rat glomerular cell cultures grown in the
absence of complement in fully artificial medium. Since several
authors assumed that in dialysis patients plasma levels of PGE2,
TXB2 and interleukin 1(11-1) rise after contact of blood with the
membrane, we elected to determine PGE2, TXB2 and interleu-
kin 1 release as well as oxygen radical formation.
Our data show that brief contact of various cells with
cuprammonium causes a rise in intracellular Ca followed by
release of PGE, TXB-, and IL-i independent of complement.
The Ca signal and the mediator release could stereospecifi-
cally be inhibited by carbohydrates.
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Types of cells
Human monocytes. Mononuclear leukocytes were obtained
from heparinized blood of blood donors by centrifugation on
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Lymphoprep (Molter Co., Bammental, FRG). The cells were
repeatedly washed in RPM! 1640 (Seromed Co., Berlin, FRG)
and enriched by adherence to plastic dishes. The monocytes
were suspended in RPM! 1640, containing 5% fetal calf serum
(Sebio, Walchsing, FRG) and placed in multiwell plates. Each
well contained 2 x 106 monocytes in I ml medium.
Platelets. Platelets were prepared by continuous cell separa-
tion (Fenwal, CS-3000) in the blood bank of Department of
Immunology, Heidelberg, FRG. They were washed several
times in Hanks' balanced salt solution (HBSS) and adjusted to
l08/ml. The platelets were free of contamination by nucleated
cells as judged by phase contrast microscropy.
Glomerular epithelialcells. Male Sprague-Dawley rats (200 g)
were anaesthesized with ether and exsanguinated. The kidneys
were removed under sterile conditions. Isolation of glomeruli
was carried out on ice by sieving cortex homogenates using
modified Greenspon-Krakower procedure [101. Contamination
of the glomerular preparations with tubular fragments was less
tha 3%. Glomeruli were seeded onto multiwell plates (Becton
and Dickinson Co., Mechelen, Belgium) at a density of 400
glomeruli/well in Dulbecco's modified medium (Gibco, Eg-
genstein, FRG) with FCS to yield a final concentration of 5%,
insulin 500 cg, and penicillin/streptomycin 500 UI 100 ml me-
dium.
By day 3, the majority of glomeruli had attached to the plates.
Non-adhering glomeruli and cell debris were removed by wash-
ing. For further culture, FCS-free (and by implication C-free)
CPSR-1 medium (Sigma Co., München, FRG) was used. By
days three to five, epithelial cells began to sprout, and by day 8
a lawn of uniform cobblestone-like glomerular epithelial cell
outgrowth surrounded the attached glomeruli [ill. At this time,
no single irregularly shaped or stellate mesangial cells or small
round cells resembling macrophages were seen.
Human monocytes (U937). U937 histiocytoma cell line (Dr.
Falk, DKFZ, Heidelberg, FPG) was raised in RPM!, 10% FCS,
glutamine 1% and antibiotics as above. They were placed in
multiwell plates at a density of I x l06/ml.
Isolation of polymorphonuclear leucocytes (PMN). Heparin-
ized human blood (10 ml) was centrifuged on Ficoll-Hypaque.
The fraction containing the erythrocytes and the PMN was
recovered and washed in 0.9% saline. The erythrocytes were
lyzed by repeated osmotic lysis in 0.2% saline. The PMN were
suspended in Hanks' balanced salt solution (HBSS) and
adjusted to 4 x l06/ml in HBSS containing cytochrome (80 sM).
HL-60 cell culture. HL-60 myelomonocytic leukemia cells
were grown in RPMI-1640 supplemented with 10% FCS, gluta-
mine 1% and antibiotics as above. Cellular differentiation was
achieved by culturing the cells for seven days in the presence of
Me2SO (1.3% vol/vol).
Materials used
Membranes. Cuprammonium cellulose was used in either flat
membrane or bead configuration. According to the supplier's
information all membranes were free of glycerol and had not
been sterilized with ethylene oxide.
Membranes were produced by means of the cuoxam-process,
the procedure being described by Malkomes and Reichle [12].
Modified cuprammonium cellulose (Hemophan') was produced
and supplied by Enka AG (Wuppertal, FRG).
In this cellulosic membrane a small proportion of the cellu-
lose OH-groups was substituted with tertiary amino groups.
The concentration of amino ligands in the resulting cellulose
was kept extremely low and amounted to less than 1% of OH
groups. Beads were obtained by grinding small pieces of the
membrane material previously cooled in liquid nitrogen. The
resulting particles were screened through a sieve with a mesh
size of 0.125 mm. Beads of a diameter smaller than 0.125 mm
were used in the experiments.
Endotoxin. Lipopolysaccharide from S. Minnesota was pur-
chased from Difco (Detroit, Michigan, USA). For stimulation of
GEC amounts ranging from 0.5 to 2 g were used.
To exclude interference by endotoxin, CU membranes were
preincubated with polymyxin B (Sebio, Walchsing, FRG), final
concentration I g/ml.
Glass beads (approximately 0.1 mm diameter), obtained from
Ham Glaswerke (Eberbach, FRG), were siliconized by incuba-
tion with a silicon solution (Serva Co., Heidelberg, FRG) for
one hour at 100°C. The beads were then washed repeatedly in
RPM! medium.
For preparation of anti-C3 F(ab)2 fragments, 1 ml of antibody
to C3 (!gG preparation) from Dako Company (Copenhagen,
Denmark) was digested with pepsin (1%) from Serva Co. The
F(ab)2 fragments were isolated by gel filtration on Sephacel
S-200 (Pharmacia Co., Uppsala, Sweden) and equilibrated with
phosphate buffered saline (0.01 M; pH 7.8). The F(ab)2 were
identified by dot blot analysis. Functional activity of the anti-
human-C3-F(ab) fragment was assessed by inhibition of func-
tional C3 activity in a hemolysis assay. Anti-human-IgG (Fc)
and anti-human-IgG (Fab) were purchased from Dianova C.,
Hamburg.
Experimental protocol
All incubations were carried out at 37°C. Cuprammonium
was used either in membrane configuration, that is, cut into I
cm2 squares or in bead configuration (particles of irregular
spherical size approximately 100 sm across). Prior to use,
membranes and beads were washed extensively with sterile
0.9% NaCl and RMPI, When adherent cells were used
(monocytes or GEC), the membranes were temporarily placed
into the well (Falcon plates) containing the adherent cells for
two to five minutes and were then removed. Microscopically,
the cell lawn was still intact after removal of the membrane. By
protein determination (Lowry-test in SDS solubilized cells) it
could be shown that loss of cells during the incubation proce-
dure was negligible. The cells were incubated further; superna-
tants were taken at timed intervals and centrifuged to remove
cell debris. All experiments were run in triplicate or quadrupli-
cate.
For the experiments with platelets, the membranes were
placed first into culture dishes, then the platelet suspension was
added. During incubation, the plates were gently moved on a
rocker platform (30 cycles/mm). Metabolic inhibitors, that is,
bromophenacylbromide (Sigma Co.), indomethacin or cyclo-
heximide (Serva Co.), were added to the medium prior to
addition of CU to yield a final concentration as specified in the
Tables and Figures. The monosaccharides D- and L-fucose, D-
and L-mannose (Serva Co.) were added to yield a final concen-
tration of 5 mM.
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Analytical techniques
Determination of PGE2 and TXB2. PGE2 and TXB2 were
determined by radioimmunoassay according to Grimm et a!
[131.
Determination of phosphatidylinositol-turnover. U937 or HL-
60 cells were preincubated in the presence of '4C-labeled oleic
acid (5 pCi/rn!; specific activity 50 to 60 mCi/mM of l4Clabeled
arachidonic acid (0.5 pCi/mi; specific activity 58 mCi/mM;
Buchler Amersham, Braunschweig, FRG) for 48 hours with
RPM! in the presence of 10% FCS. The labeled cells were
washed several times with RPM! and then cultured in Falcon
dishes in the presence of CU membranes (1 cm2) in medium
containing lithium chloride (10 mM). At timed intervals, cells
were removed and phospholipids were extracted with 1-120/
methanol/chloroform (1.8:2:2). The chloroform phase was dried
under a stream of nitrogen, applied to a silica plastic plate
(Merck Co., Darmstadt, FRG) and separated by thin layer
chromatography. Phosphatidylinositol and neutral lipids were
separated as described by Habenicht et al [14, 15].
Phospholipids were separated by two-dimensional thin layer
chromatography using as solvent system chloroform, methanol,
acetic acid, 0.1 M boric acid (75/45/12/4.5 vol/vol) in the first
dimension and subsequently chloroform, acetone, methanol,
acetic acid, 0.1 M boric acid (75/30/15/15/6.75 vol/vol) in the
second dimension. Neutral lipids were isolated by chromatog-
raphy using a solvent system consisting of hexane, diethylether,
methanol, acetic acid (90/20/3/2 vol/vol). The plates were dried
at room temperature, cut into 0.5 cm pieces and placed into 3 ml
Unisolve (Zinsser Co., Frankfurt, FRG). Appropriate lipid
standards were used as controls.
Analysis of 3H inositol phosphates. HL-60 cells (106/ml)
differentiated as described above [16], were incubated with 3H
inositol (2 sCi/ml; specific activity 12 mCi/mM; Buchler
Amersham, Braunschweig, FRG) for 48 hours. As positive
control for cell stimulation, f-Met-Leu-Phe purchased from
Serva Co. was used in a final concentration of 10 M. 3H
labeled inositol phosphates were measured by anion exchange
chromatography according to the method of Downes and
Michell [17].
Human polymorphonuclear leucocytes (4 x 106/ml) were
suspended in cytochrome C (Serva Co.), 80 tmol, and placed in
Multiwell plates coated with cuprammonium membranes. After
30 minute incubation time in HBSS, reduction of cytochrome C
as an index of 02 was measured photometrically [11]. The
cytochrome C reduction was inhibitable by superoxide dismu-
tase 100 U/mI (Serva Company).
Inter/eukin 1 assay. Supernatants of CU stimulated mono-
cytes were tested for interleukin 1 (IL-I) activity which was
assessed by measuring 3H-thymidine incorporation in LPS low
responder mouse thymocytes [18]. To validate the method,
antibody to interleukin I (Genzyme Co., Munchen, FRG) which
recognizes both alpha- and beta IL-I was added to the incuba-
tion; it abolished the proliferation of thymocytes completely.
Quin-2 -assay. Platelets (l08/ml) or U937 cells (106/ml) were
incubated with Quin-2-acetoxymethylester (50 /Lmol), obtained
from Amersham Buchler (Braunschweig, FRG), for 30 minutes
at 37°C. After preloading, cells were washed extensively and
resuspended in the appropriate medium. Quin-2-fluorescence in
the presence or absence of membrane contact was recorded
Fig. 1. TXB2 release from platelets of three different donors by unmod-
ified cuprammonium in the absence of complement. 108 platelets were
incubated in I ml with CU (1 cm2) at 37°C. The Figure shows TXB2 in
the supernatant as a function of incubation time. All measurements are
in triplicate. Values are corrected for basal release at each time point.
with a Perkin Elmer MPF-44-spectrofiuorometer as described
[19, 20]. The intracellular Ca levels were calculated as
described in [20].
Results
Effects of contact with cuprammonium on platelets
When platelets were briefly exposed to CU membranes (1
cm2) for two minutes (shorter exposure was not mechanically
feasible), transient release of TXB2 into the supernatant was
observed (Fig. 1). TXB2 levels subsequently decreased, possi-
bly by biodegradation to reaction products not recogilized by
the antibody or by adsorption. Similar stimulation of TXB2
release was not observed with covalently modified cationic
membranes (DEAE-cuprammonium). Figure 1 shows the re-
suits of experiments done with platelets of three different
donors.
Effects of contact with cuprammonium on glomerular
epithelial cells
Glomerular epithelial cells (GEC), obtained as outgrowth
cultures of rat glomeruli, were used as model cells since they
can be kept in serum-free, and thus complement-free, medium
(Fig. 2). Pilot studies had shown that these cells do not produce
complement components (ELISA with the supernatant, using
anti-C3-antibody). Exposure of GEC to cuprammonium in
membrane (Fig. 2) or bead configuration (data not shown)
caused progressive release of PGE2 with time. Figure 2 shows
one representative example of ten experiments. The release
was triggered by even brief exposure of cells to cupram-
monium, approximately two minutes. Mechanical irritation of
cells is presumably not responsible for stimulation of PGE2
20 30
Incubation time, minutes
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Fig. 2. PGE2 release from rat glomerular epithelial cells by CU in the
absence of complement. A. CU (1 cm2) was placed into culture dishes
on top of a confluent layer of glomerular epithelial cells. After 2 mm, the
membrane was removed and the cells were incubated for the time
specified on the abscissa. Symbols are: unmodified CU induced release
of PGE2 (•); markedly less release was seen with DEAE-derivatised
CU (A). B. Release of PGE2 from cells derived from nine different
cultures incubated as above for 30 mm. Values are corrected for basal
release.
Fig. 3. Induction of fL-I and POE2 synthesis in human monocytes by
contact with cuprammonium in absence of complement. Monocytes (2
x 10) adherent to culture dishes were incubated with CU (1 cm2) at
37°C. After various times the supernatants were removed, centrifuged
and tested for Il-I activity, assessed by proliferative response of mouse
thymocytes 1191. Proliferation was tested by 3H dTd incorporation. The
proliferative response was inhibited by addition of anti-Il-i (final cone.
1%), when the supernatants had been incubated with the antibody prior
to addition to the thymocytes (U); (•) shows the proliferation with
unstimulated monocyte-supernatants (B). In the same samples POE
was determined by radioimmunoassay (A).
synthesis, since the effect was not seen after contact with
covalently modified cuprammonium. Furthermore, stimulation
due to endotoxin contamination of cuprammonium membranes
seems unlikely, since under the above conditions GEC were
unresponsive to 0.5 to 2 g endotoxin per well within the time
studied.
Effects of contact with duprammonium on blood monocytes
or U937 cells
When monocytes isolated from peripheral blood were incu-
bated with CU in membrane or bead configuration for various
times, an increase of POE2 release into the supernatant with
time relative to values in controls was observed (Fig. 3). Similar
data were obtained with U937 cells cultivated under serum-free
conditions. Prostanoid synthesis was induced by the shortest
contact time mechanically feasible, that is, two minutes. Stim-
ulation of prostanoid release was also seen when membranes
were preincubated with polymyxin B or when polymyxin B was
present during incubation timç (Table 1). Therefore, an artefact
from contamination of CU with endotoxin is unlikely. Further-
more, to exclude participation of C3 In stimulation of POE2
synthesis, incubations were carried out in the presence of
cycloheximide or anti-human-C3-F(ab)2. Both maneuvers failed
to interfere with cuprammonium-induced stimulation of PGE2
synthesis, Therefore, an artefact resulting from synthesis or
release of C3 by U937 is unlikely. The experiments with
cycloheximide also exclude possible effects of other comple-
ment split products such as C5a or factor B. In a further set of
experiments the effect of cuprammonium on the IL-l-synthesis
was tested. Adherent human monocytes were incubated with
duprammonium (1 cm2) for various times (up to 24 hr). After six
hours, release of IL-i was seen, which increased up to 24 hours.
The specificity of the IL-i assay was assessed with an antibody
to IL-i (Fig. 3).
POE2 ng/ml
Basal release 3.4 1.4
Cuprammonium 31.8 4.1
CU + polymyxin B I sg/ml 32.8 4.8
CU + cycloheximide 10 jsg/ml 29.8 5.8
CU + anti-C3F(ab)2 15 pg/mi 29.9 7.8
Anti-C3F(ab)2 15 pg/mI 3.9 2.1
Effects of contact with cuprammonium on 02 radical
formation by human polymorphonuclear leucocytes (PMN)
When PMN were incubated with cuprammonium in mem-
brane configuration, release of oxygen radicals 02 was in-
creased above basal levels (0.9 nM) by 30 minute exposure to
cuprammonium (1 cm2) to 4.2 flM. The effect was inhibitable by
superoxide dismutase. This compares with 5.5 nM 30 minutes
after exposure to 100 g/ml PMA or 3.9 flM 30 minutes after
exposure to 100 /ml zymosan (all measurements in dupli-
cate).
Effects of contact with cuprammonium on
phosphatidylinositol turnover and cytosolic Ca + in
U937 cells
Release of POE2 or TXB2 from U937, glomerular epithelial
cells or platelets, respectively, could be inhibited by the phos-
pholipase A2 blocker bromophenacylbromide or the cyclooxy-
genase inhibitor indomethacin, indicating that CU stimulated de
novo POE2 synthesis (data shown for U937 in Table 2). Preload-
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Table 1. Cuprammonium contact induced POE2 synthesis in U937
cells
All experiments (106 cells/mI) were run in four parallel cultures. From
the supernatants the POE determination was done in duplicate. 5c SD;
no overlap of values between basal and stimulated values.
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PGE2 TXB2
nglml
Basal release 2.8 O.7a 10.4 1.6
Cuprammonium (CU) 25.4 3.8 77.4 2.8
Additions % Inhibition
CU + bromophenacylbromide 5 fLM 85% 78%
CU + indomethacin J0tM
CU + Quin-21' 50 p.M
89% 100%
56% 64%
ing of cells with Quin-2 partially inhibited generation of arachi-
donic acid products; since this fluorochrome buffers cytosolic
the finding suggested that Ca-dependent pathways
were involved. To further clarify the role of Ca, changes of
cytosolic Ca were measured in U937 cells, in platelets and
HL-60 cells exposed to CU membranes. Quin-2 was used as an
intracellular Ca + indicator. With all cell types used, a repro-
ducable increase in fluorescence was seen when CU mem-
branes were placed directly into the cuvette together with the
cells. In U937, basal Ca levels were approximately 170 nM
and increased by up to 100 n. The increase in intracellular
Ca + was independent of the Ca levels in the medium (0.5 to 2
mM); it was also seen when cells were suspended in nominally
Ca-free media, suggesting that Ca was mobilized from
intracellular stores.
To further explore the membrane signal involved, we tested
phosphatidylinositol (P1) breakdown and generation of diacyl-
glycerol (DG) and inositoltriphosphate (1P3). Ten minutes after
contact with cuprammonium, DG generation was demonstrable
which was accompanied by breakdown of P1 (Fig. 4). 1P3,
however, was not detectable. Using different stimuli, such as
f-Met-Leu-Phe, generation of 1P3 was observed, indicating that
the system was able to detect a P1 response. Since experiments
were performed in the presence of lithium chloride, enhanced
breakdown of 1P3 was improbable, suggesting that cupram-
monium triggered a different pathway of P1 breakdown (Table
3).
Studies on the nature of the signal in CU membranes
eliciting the monocyte response
As described above, even brief exposure to unmodified CU in
membrane or bead configuration induced de novo synthesis of
PGE2 or TXB2. Scanning electron microscopy revealed that the
edges of cut CU membranes were rather irregular and serrated.
To exclude artefacts from non-specific frustrated phagocytosis,
we placed cells into Boyden chambers, a device in which cells
were only in contact with a smooth and plain surface. Under
these conditions, PGE2 synthesis was triggered in a similar
fashion (data not shown). As a further control, we exposed
monocytes to siliconized glass beads. This failed to trigger
PGE2 release within the time period studied. Thus it appeared
that POE2 synthesis is initiated by a specific property of
unmodified CU. This assumption is supported by the fact that
1 5 10 15 20 30
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Fig. 4. Effect of con tact with cuprammonium on DG generation in
U937 inonocytes. After brief (2 mm) contact with CU reduction of '4C
oleic acid tracer in the P1 fraction (•) was noted. This was paralleled by
an increase of the proportion of tracer recovered in the diacylglycerol
fraction (A). Approximately 5000 cpm were recovered in the total
membrane lipid fraction of 106 unstimulated cells. All measurements are
in duplicate.
1P3 DG
cpmIlO6 cells
Control 70 804 24
Cuprammonium
I mm 77.5 19.2 793 62
2 mm 77.4 17.4 882 86
10mm 65 2.1 1027 ll6
f-Met-Leu-Phe
1 mm 85 a 985 149
2mm 93± l2.5a 923
10mm 75±1.2 903±82
Cells were treated with CU membranes or as positive control with f-
Met-Leu-Phe (l0 M) for different times in the presence of lithium
chloride (10 mM). The incubations were stopped by the addition of 10%
TCA. Water soluble metabolites (1P3 and DG) were extracted and
measured. The amount of radioactivity is expressed as cpm/106 cells.
a p < 0.05.
covalently modified cationic cuprammonium membranes did
not—or to a lesser degree—stimulate PGE2 or TXB2 synthesis
as documented in Figure 2. Finally, POE2 release and cytosolicCa signal (Quin 2) were inhibited in a stereospecific fashion
when 5 mtvi L-fucose was present in the reaction mixture. Other
monosaccharides failed to inhibit PGE2 synthesis. None of the
monosaccharides affected basal POE2 synthesis or the incre-
ment of POE2 synthesis in response to the calcium ionophore A
23187 (Table 4). The effect of monosaccharides on the Ca
signal in U937 cells (Table 4) and HL-60 cells were reproduced
in three independent experiments.
Discussion
The results clearly demonstrate a complement-independent
activation of human monocytes, monocytic cell line U937 and
Table 2. Inhibition of cuprammonium contact induced PGE2 or TXB2
synthesis by U937 cells
130
120
0
110
00
100
90
80
Data as SD; all experiments were done in four parallel samples
(106 monocytes/mI).
a Measured after 20 mm incubation time.b Preloading of cells by incubating in 50 p.M Quin-2 Hanks' BSS.
Table 3. HL-60 cells were prelabelled for 48 hours with 3H inositol
or 14C oleic acid
72 Betz et al: Activation of monocytes by cuprammonium
Table 4. Effect of incubation with various monosaccharides (all 5
mM) on POE2 synthesis by, and changes of cytosolic Ca in, U937
cells (l06/ml)
PGE2 Ca
Additions ng/ml flM
Control (resting) 7.1 6.8 168 6.3
Cuprammonium (CU) 24.1 5.8 289 4.1
CU + L-fucose 7.3 3 160 4.1
CU + D-fucose 18.4 6.1 264 7.4
CU + D-mannose 24.0 4.8 294 3.9
CU + L-mannose 27.4 3.8 301 4.1
CU + galactosamine 25.9 4.0 299 8.7
All experiments were done in four parallel cultures; the POE determi-
nation was done as duplicates; all carbohydrates 5 mM; data as SD.
Control experiments with resting control cells and monosaccharides
alone did not show significant changes. Monosaccharides did not
interfere with POE2 stimulation by unrelated signals, such as calcium
ionophore A 23187 (data not shown).
HL-60, PMN, platelets or rat glomerular epithelial cells (grown
in fully synthetic medium) by brief exposure to flat sheet
cuprammonium membranes. Rat glomerular epithelial cells
were chosen as a model of cells grown in the assured absence of
C. Activated cells showed a burst release of oxygen radicals
and a fast but transient increase of net PGE2 or TXB2 release,
respectively. On the basis of experiments of others it is likely
that lipoxygenase products were also released, but this was not
directly measured. Furthermore, delayed increase of interleu-
kin I release assessed by functional assay was observed. As to
the mechanism of activation, in U937 or HL 60 cells a fast
increase of cytosolic Ca + (Quin 2 technique) was noted.
Moreover, breakdown of P1 was observed with a concomitant
increase in DG. 1P3 levels, however, were not affected.
Several potential artefacts were considered and excluded.
The conclusion that C is not involved rests on the assumption
that even trace amounts of C3 are absent. This postulate is
impossible to fulfill for washed platelets and is even difficult for
monocytes which synthesize C3 at a slow rate [21]. To exclude
traces of C we examined in vitro cultures of rat glomerular
epithelial cells raised in the absence of serum in completely
synthetic medium. Furthermore, we carried out incubation of
monocytes in the presence of cycloheximide (to prevent protein
synthesis) and F(ab)2 fragments to C3 (to bind traces of C3
without cell activation). Both maneuvers did not abolish cell
activation by CU.
Endotoxin is a uniquely potent activator of monocytes [22]
and other cells. Even fetal calf sera may not be completely
endotoxin-free. It has also been claimed that cuprammonium
membranes contain endotoxin, more specifically, material re-
acting in the limulus amoebocyte assay [23]; more recently, it
has been demonstrated that the reactive material represented
13-glucanes and not endotoxin [24]. Nevertheless, we carefully
excluded endotoxin artefacts by several maneuvers. We always
carried out appropriate control experiments in the presence of
polymyxin, which is known to obliterate endotoxin effects. We
compared the effects of membrane contact with the effects of
known amounts of bacterial LPS. None of these control exper-
iments suggested that endotoxin contamination was responsible
for the results.
We feel that non-specific cytotoxicity is excluded by several
lines of evidence. First, measurements of LDH in the incuba-
tion media gave consistently negative results. Second, on
ultrastructural examination, mitochondrial membranes were
well preserved in activated monocytes and glomerular cells,
respectively. Third, glomerular epithelial cells in culture con-
tinued to adhere and exhibited normal growth potential after
exposure to CU. Fourth, trypan-blue was consistently excluded
by glomerular epithelial cells.
We also considered that activation might reflect frustrated
phagocytosis. Indeed, microscopic examination of the cut
membranes showed that surfaces were not completely smooth,
and that particularly the edges were irregular and serrated. To
circumvent this problem, control experiments were carried out
using a modification of Boyden chamber which avoids exposure
of cells to cut membrane edges. Such change of membrane
geometry did not affect cell activation. Furthermore, control
experiments with siliconized glass beads, while stimulating
PGE2 synthesis in monocytes, resulted in delayed activation,
the time course of which was completely different from that
seen with CU.
The interpretation of the time course of activation of PG
metabolism is delicate. POE2 concentrations represent the
balance between synthesis and breakdown or binding, respec-
tively. Since the latter were not measured we cannot exclude
the possibility that the late fall of PGE2 or TXB2 indicates more
extensive breakdown or binding despite ongoing increased
synthesis, respectively.
Activation of P1 cycle with the associated rise in cytosolic
Ca has recently been recognized to underly activation of
monocyte (and other cells) by different agonists [reviewed in
25]. While being aware of the difficulties of arriving at absolute
figures with the Quin-2 technique, we estimated resting Ca
levels at approximately 170 nM. Thirty seconds and one minute
after contact cytosolic Ca + increased up to approximately 270
tiM in U937 cells or HL-60 cells.
To explore whether signal transmission via P1 cycle was
involved, we examined the steady state concentrations of P1
cycle intermediates in '4C oleic or arachidonic acid-prelabeled
U937-monocytes or HL-60 cells. Whereas breakdown of P1 and
generation of DO was seen, 1P3 was not noted in a system which
was able to detect 1P3 generation in response to a defined
stimulus, that is, f-Met-Leu-Phe [16], and in which rapid
breakdown of 1P3 was prevented by lithium chloride.
The data are consistent with the findings in other systems
where DG generation was seen independently of 1P3 generation
[26]. With respect to CU-mediated activation it has been
postulated that carbohydrate-derived OH groups are crucial for
reaction with the internal labile thioester group of C3 [271. To
explore a potential role of carbohydrate groups in providing the
initial signal for C-independent activation of monocytes and
other cells, we chose two approaches. First, we examined
cuprammonium material in which reactive hydroxyl groups
were partially eliminated by limited covalent modification, that
is, limited derivation with diethylaminoethane groups.
The limited derivatisation has previously been shown to
drastically reduce C-activation [28] primarily by enhancing
binding of regulatory factor H [29]. Second, we incubated
monocytes with cuprammonium in the presence of monosac-
charides with the aim to specifically inhibit carbohydrate/cell
surface interactions. Covalent modifications drastically reduced
cell activation. This is of particular note since incubations were
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performed under conditions where C-activation [29] certainly
did not play a role. Since only a minor proportion of hydroxyl
groups on the membrane surface were derived we conclude that
only a very limited number of surface molecules are involved
in, and sufficient for, providing the activation signal. Finally,
co-incubation experiments showed inhibition by L-fucose of cell
activation. The effects appear to be stereospecific since similar
inhibition was not seen with the steroisomer D-fucose or other
monosaccharides. Analysis of CU carbohydrate content, using
gaschromatography/mass spectrometry failed to yield evidence
for presence of fucose (detection limit 1 pM). We cautiously
conclude that pentose(s) or complementary structures may be
involved in the primary cell/cuprammonium interaction.
We wish to point out three potential implications of our
findings: in the endeavor to construct more biocompatible
membranes (and more generally blood contact surfaces), the
demonstration of C-independent blood cell activation provides
a new test system to rationally design new membranes. Second,
the recent concern that monocyte activation, and more specif-
ically generation of interleukin 1, may play a role in the genesis
of some long-term complications of dialysis [3] makes this new
pathway of dialysis, acquired monocyte activation, clinically
relevant. Third, the demonstration that platelet activation by
cuprammonium is inhibitable by limited derivation of cupram-
monium opens new possibilities to design more thromboresist-
ent membranes by selected chemical modification.
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